Achilles Therapeutics Plc Stock Current Liabilities
ACHLDelisted Stock | USD 1.48 0.01 0.68% |
Achilles Therapeutics PLC fundamentals help investors to digest information that contributes to Achilles Therapeutics' financial success or failures. It also enables traders to predict the movement of Achilles Stock. The fundamental analysis module provides a way to measure Achilles Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achilles Therapeutics stock.
Achilles |
Achilles Therapeutics PLC Company Current Liabilities Analysis
Achilles Therapeutics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
In accordance with the recently published financial statements, Achilles Therapeutics PLC has a Current Liabilities of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Achilles Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achilles Therapeutics' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics of similar companies.Achilles Therapeutics is currently under evaluation in current liabilities category among its peers.
Achilles Fundamentals
Return On Equity | -0.52 | ||||
Return On Asset | -0.3 | ||||
Current Valuation | (19.21 M) | ||||
Shares Outstanding | 41.1 M | ||||
Shares Owned By Insiders | 6.28 % | ||||
Shares Owned By Institutions | 83.09 % | ||||
Number Of Shares Shorted | 797.85 K | ||||
Price To Earning | 0.49 X | ||||
Price To Book | 0.59 X | ||||
EBITDA | (70.44 M) | ||||
Net Income | (69.94 M) | ||||
Cash And Equivalents | 201.6 M | ||||
Cash Per Share | 4.94 X | ||||
Total Debt | 4.62 M | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 11.45 X | ||||
Book Value Per Share | 2.51 X | ||||
Cash Flow From Operations | (48.45 M) | ||||
Short Ratio | 0.23 X | ||||
Earnings Per Share | (1.66) X | ||||
Price To Earnings To Growth | (0.31) X | ||||
Target Price | 0.5 | ||||
Number Of Employees | 204 | ||||
Beta | 1.25 | ||||
Market Capitalization | 63.22 M | ||||
Total Asset | 161.46 M | ||||
Retained Earnings | (259.95 M) | ||||
Working Capital | 128.64 M | ||||
Net Asset | 161.46 M |
About Achilles Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achilles Therapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achilles Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achilles Therapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Directory Find actively traded commodities issued by global exchanges |